Physician

KT104-16 and KT104-96 - PVL EVIGENE

EU & Canada: For in vitro diagnostic use (CE-IVD.
US: For research use only.  Not for use in diagnostic procedures.

PVL EVIGENE provides rapid and acurate detection of the lukS-lukF-PV genes in isolates of S. aureus.

Available in 16 or 96 tests formats.

Features and Benefits

PVL EVIGENE, 16 tests (Cat. No. KT104-16) *New* 
PVL EVIGENE, 96 tests (Cat. No. KT104-96)  

PVL – Panton-Valentine leukocidin
PVL (Panton-Valentine leukocidin) is a virulence factor closely associated with community-acquired MRSA.  80-90% of Community-Acquired MRSA are PVL-positive. S. aureus and MRSA have long been recognized as leading causes of hospital-acquired infections, but cases of community-acquired MRSA (CA-MRSA) causing aggressive and difficult to treat infections, even in otherwise healthy adults and children, are on the rise worldwide. 

Panton-Valentine leukocidin (PVL) is a cytotoxin virulence factor associated with severe, rapidly progressive, systemic disease including soft tissue infections and necrotising pneumonia.  While PVL is mostly associated with CA-MRSA, PVL positive strains are showing up more frequently in hospitalized patients causing serious infections and requiring more hospitals to develop strategies to detect and control the bacteria.(1)

1 Gorwitz et al.  Summary of an experts’ meeting convened by the Centers for Disease Control and Prevention. 2006. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5126a1.htm.